osthol has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, DC; Chen, MK; Chuang, YC; Hsi, YT; Hsieh, MJ; Lin, CC; Lin, SH; Liu, PY; Lo, YS | 1 |
| Guo, B; Han, X; Liu, S; Sun, Z; Ye, Y | 1 |
2 other study(ies) available for osthol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Osthole induces human nasopharyngeal cancer cells apoptosis through Fas-Fas ligand and mitochondrial pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Caspases; Cell Line, Tumor; Cell Proliferation; Coumarins; Fas Ligand Protein; fas Receptor; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2018 |
Combination treatment with platycodin D and osthole inhibits cell proliferation and invasion in mammary carcinoma cell lines.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Coumarins; Gene Expression Regulation, Neoplastic; Humans; Mice; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Saponins; Smad Proteins; Transforming Growth Factor beta; Triterpenes | 2013 |